BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Balkwill F, Montfort A, Capasso M. B regulatory cells in cancer. Trends Immunol. 2013;34:169-173. [PMID: 23206438 DOI: 10.1016/j.it.2012.10.007] [Cited by in Crossref: 82] [Cited by in F6Publishing: 77] [Article Influence: 9.1] [Reference Citation Analysis]
Number Citing Articles
1 Taipale K, Liikanen I, Juhila J, Turkki R, Tähtinen S, Kankainen M, Vassilev L, Ristimäki A, Koski A, Kanerva A, Diaconu I, Cerullo V, Vähä-Koskela M, Oksanen M, Linder N, Joensuu T, Lundin J, Hemminki A. Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus. Mol Ther 2016;24:175-83. [PMID: 26310629 DOI: 10.1038/mt.2015.143] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
2 Zhang Y, Xu J, Zhang N, Chen M, Wang H, Zhu D. Targeting the tumour immune microenvironment for cancer therapy in human gastrointestinal malignancies. Cancer Letters 2019;458:123-35. [DOI: 10.1016/j.canlet.2019.05.017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
3 Boelens JJ, Hosszu KK, Nierkens S. Immune Monitoring After Allogeneic Hematopoietic Cell Transplantation: Toward Practical Guidelines and Standardization. Front Pediatr 2020;8:454. [PMID: 32974239 DOI: 10.3389/fped.2020.00454] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Lizotte PH, Ivanova EV, Awad MM, Jones RE, Keogh L, Liu H, Dries R, Almonte C, Herter-Sprie GS, Santos A, Feeney NB, Paweletz CP, Kulkarni MM, Bass AJ, Rustgi AK, Yuan GC, Kufe DW, Jänne PA, Hammerman PS, Sholl LM, Hodi FS, Richards WG, Bueno R, English JM, Bittinger MA, Wong KK. Multiparametric profiling of non-small-cell lung cancers reveals distinct immunophenotypes. JCI Insight 2016;1:e89014. [PMID: 27699239 DOI: 10.1172/jci.insight.89014] [Cited by in Crossref: 71] [Cited by in F6Publishing: 68] [Article Influence: 14.2] [Reference Citation Analysis]
5 Becht E, Giraldo NA, Germain C, de Reyniès A, Laurent-puig P, Zucman-rossi J, Dieu-nosjean M, Sautès-fridman C, Fridman WH. Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers. Tumor Immunology. Elsevier; 2016. pp. 95-190. [DOI: 10.1016/bs.ai.2015.12.002] [Cited by in Crossref: 102] [Cited by in F6Publishing: 94] [Article Influence: 20.4] [Reference Citation Analysis]
6 Montfort A, Pearce O, Maniati E, Vincent BG, Bixby L, Böhm S, Dowe T, Wilkes EH, Chakravarty P, Thompson R, Topping J, Cutillas PR, Lockley M, Serody JS, Capasso M, Balkwill FR. A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian Metastases. Clin Cancer Res 2017;23:250-62. [PMID: 27354470 DOI: 10.1158/1078-0432.CCR-16-0081] [Cited by in Crossref: 65] [Cited by in F6Publishing: 38] [Article Influence: 13.0] [Reference Citation Analysis]
7 Leong TL, Bryant VL. B cells in lung cancer-not just a bystander cell: a literature review. Transl Lung Cancer Res 2021;10:2830-41. [PMID: 34295681 DOI: 10.21037/tlcr-20-788] [Reference Citation Analysis]
8 Li Z, Liu X, Guo R, Wang P. TIM-3 plays a more important role than PD-1 in the functional impairments of cytotoxic T cells of malignant Schwannomas. Tumour Biol 2017;39:1010428317698352. [PMID: 28475007 DOI: 10.1177/1010428317698352] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
9 Sharonov GV, Serebrovskaya EO, Yuzhakova DV, Britanova OV, Chudakov DM. B cells, plasma cells and antibody repertoires in the tumour microenvironment. Nat Rev Immunol 2020;20:294-307. [DOI: 10.1038/s41577-019-0257-x] [Cited by in Crossref: 86] [Cited by in F6Publishing: 71] [Article Influence: 86.0] [Reference Citation Analysis]
10 Shimabukuro-Vornhagen A, Schlößer HA, Gryschok L, Malcher J, Wennhold K, Garcia-Marquez M, Herbold T, Neuhaus LS, Becker HJ, Fiedler A, Scherwitz P, Koslowsky T, Hake R, Stippel DL, Hölscher AH, Eidt S, Hallek M, Theurich S, von Bergwelt-Baildon MS. Characterization of tumor-associated B-cell subsets in patients with colorectal cancer. Oncotarget 2014;5:4651-64. [PMID: 25026291 DOI: 10.18632/oncotarget.1701] [Cited by in Crossref: 63] [Cited by in F6Publishing: 55] [Article Influence: 10.5] [Reference Citation Analysis]
11 Wang H, Xu W, Shao Q, Ding Q. miR-21 silencing ameliorates experimental autoimmune encephalomyelitis by promoting the differentiation of IL-10-producing B cells. Oncotarget 2017;8:94069-79. [PMID: 29212210 DOI: 10.18632/oncotarget.21578] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
12 Siewe B, Pham JT, Cohen M, Hessol NA, Levine A, Martinez-maza O, Landay A. Dysregulated B-cell TLR2 expression and elevated regulatory B-cell frequency precede the diagnosis of AIDS-related non-Hodgkin lymphoma: . AIDS 2015;29:1659-64. [DOI: 10.1097/qad.000000000000068] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
13 Garnelo M, Tan A, Her Z, Yeong J, Lim CJ, Chen J, Lim KH, Weber A, Chow P, Chung A, Ooi LL, Toh HC, Heikenwalder M, Ng IO, Nardin A, Chen Q, Abastado JP, Chew V. Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma. Gut. 2017;66:342-351. [PMID: 26669617 DOI: 10.1136/gutjnl-2015-310814] [Cited by in Crossref: 162] [Cited by in F6Publishing: 159] [Article Influence: 27.0] [Reference Citation Analysis]
14 Greenplate AR, Johnson DB, Ferrell PB Jr, Irish JM. Systems immune monitoring in cancer therapy. Eur J Cancer 2016;61:77-84. [PMID: 27155446 DOI: 10.1016/j.ejca.2016.03.085] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
15 Bedon L, Dal Bo M, Mossenta M, Busato D, Toffoli G, Polano M. A Novel Epigenetic Machine Learning Model to Define Risk of Progression for Hepatocellular Carcinoma Patients. Int J Mol Sci 2021;22:1075. [PMID: 33499054 DOI: 10.3390/ijms22031075] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Liu J, Wang H, Yu Q, Zheng S, Jiang Y, Liu Y, Yuan G, Qiu L. RETRACTED: Aberrant frequency of IL-10-producing B cells and its association with Treg and MDSC cells in Non Small Cell Lung Carcinoma patients. Hum Immunol 2016;77:84-9. [PMID: 26527508 DOI: 10.1016/j.humimm.2015.10.015] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
17 McCaw TR, Randall TD, Arend RC. Overcoming immune suppression with epigenetic modification in ovarian cancer. Transl Res 2019;204:31-8. [PMID: 30048638 DOI: 10.1016/j.trsl.2018.06.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
18 Bachireddy P, Burkhardt UE, Rajasagi M, Wu CJ. Haematological malignancies: at the forefront of immunotherapeutic innovation. Nat Rev Cancer 2015;15:201-15. [PMID: 25786696 DOI: 10.1038/nrc3907] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 8.3] [Reference Citation Analysis]
19 Sarajlić A, Filipović A, Janjić V, Coombes RC, Pržulj N. The role of genes co-amplified with nicastrin in breast invasive carcinoma. Breast Cancer Res Treat 2014;143:393-401. [DOI: 10.1007/s10549-013-2805-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
20 Qin M, Wang D, Fang Y, Zheng Z, Liu X, Wu F, Wang L, Li X, Hui B, Ma S, Tang W, Pan X. Current Perspectives on B Lymphocytes in the Immunobiology of Hepatocellular Carcinoma. Front Oncol 2021;11:647854. [PMID: 34235074 DOI: 10.3389/fonc.2021.647854] [Reference Citation Analysis]
21 Ricciardi M, Zanotto M, Malpeli G, Bassi G, Perbellini O, Chilosi M, Bifari F, Krampera M. Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells. Br J Cancer. 2015;112:1067-1075. [PMID: 25668006 DOI: 10.1038/bjc.2015.29] [Cited by in Crossref: 79] [Cited by in F6Publishing: 75] [Article Influence: 13.2] [Reference Citation Analysis]
22 Shen M, Wang J, Yu W, Zhang C, Liu M, Wang K, Yang L, Wei F, Wang SE, Sun Q, Ren X. A novel MDSC-induced PD-1-PD-L1+ B-cell subset in breast tumor microenvironment possesses immuno-suppressive properties. Oncoimmunology 2018;7:e1413520. [PMID: 29632731 DOI: 10.1080/2162402X.2017.1413520] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
23 Xu X, Zhang C, Trotter TN, Gowda PS, Lu Y, Ponnazhagan S, Javed A, Li J, Yang Y. Runx2 Deficiency in Osteoblasts Promotes Myeloma Progression by Altering the Bone Microenvironment at New Bone Sites. Cancer Res 2020;80:1036-48. [PMID: 31911552 DOI: 10.1158/0008-5472.CAN-19-0284] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
24 Lee MB, Lee JH, Hong SH, You JS, Nam ST, Kim HW, Park YH, Lee D, Min KY, Park YM, Kim YM, Kim HS, Choi WS. JQ1, a BET inhibitor, controls TLR4-induced IL-10 production in regulatory B cells by BRD4-NF-κB axis. BMB Rep 2017;50:640-6. [PMID: 29187284 DOI: 10.5483/bmbrep.2017.50.12.194] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 5.3] [Reference Citation Analysis]
25 Lopez-Abente J, Prieto-Sanchez A, Muñoz-Fernandez MÁ, Correa-Rocha R, Pion M. Human immunodeficiency virus type-1 induces a regulatory B cell-like phenotype in vitro. Cell Mol Immunol 2018;15:917-33. [PMID: 28713164 DOI: 10.1038/cmi.2017.48] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
26 Michaud D, Steward CR, Mirlekar B, Pylayeva-Gupta Y. Regulatory B cells in cancer. Immunol Rev 2021;299:74-92. [PMID: 33368346 DOI: 10.1111/imr.12939] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
27 Audo R, Hua C, Hahne M, Combe B, Morel J, Daien CI. Phosphatidylserine Outer Layer Translocation Is Implicated in IL-10 Secretion by Human Regulatory B Cells. PLoS One 2017;12:e0169755. [PMID: 28072868 DOI: 10.1371/journal.pone.0169755] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
28 Yuen GJ, Demissie E, Pillai S. B lymphocytes and cancer: a love-hate relationship. Trends Cancer. 2016;2:747-757. [PMID: 28626801 DOI: 10.1016/j.trecan.2016.10.010] [Cited by in Crossref: 139] [Cited by in F6Publishing: 116] [Article Influence: 46.3] [Reference Citation Analysis]
29 D'Agostino G, Cecchinato V, Uguccioni M. Chemokine Heterocomplexes and Cancer: A Novel Chapter to Be Written in Tumor Immunity. Front Immunol 2018;9:2185. [PMID: 30319638 DOI: 10.3389/fimmu.2018.02185] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
30 Cherukuri A, Ding Q, Sharma A, Mohib K, Rothstein DM. Regulatory and Effector B Cells: A New Path Toward Biomarkers and Therapeutic Targets to Improve Transplant Outcomes? Clin Lab Med 2019;39:15-29. [PMID: 30709503 DOI: 10.1016/j.cll.2018.10.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
31 Fu K, Hui B, Wang Q, Lu C, Shi W, Zhang Z, Rong D, Zhang B, Tian Z, Tang W, Cao H, Wang X, Chen Z. Single-cell RNA sequencing of immune cells in gastric cancer patients. Aging (Albany NY) 2020;12:2747-63. [PMID: 32039830 DOI: 10.18632/aging.102774] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
32 Wu H, Su Z, Barnie PA. The role of B regulatory (B10) cells in inflammatory disorders and their potential as therapeutic targets. Int Immunopharmacol 2020;78:106111. [PMID: 31881524 DOI: 10.1016/j.intimp.2019.106111] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
33 Wang SS, Liu W, Ly D, Xu H, Qu L, Zhang L. Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer. Cell Mol Immunol 2019;16:6-18. [PMID: 29628498 DOI: 10.1038/s41423-018-0027-x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 63] [Article Influence: 23.0] [Reference Citation Analysis]
34 Vallet S, Pecherstorfer M, Podar K. Adoptive cell therapy in multiple Myeloma. Expert Opin Biol Ther 2017;17:1511-22. [PMID: 28857616 DOI: 10.1080/14712598.2017.1375095] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
35 Oliveria JP, Agayby R, Gauvreau GM. Regulatory and IgE+ B Cells in Allergic Asthma. Methods Mol Biol 2021;2270:375-418. [PMID: 33479910 DOI: 10.1007/978-1-0716-1237-8_21] [Reference Citation Analysis]
36 Zhou M, Wen Z, Cheng F, Ma J, Li W, Ren H, Sheng Y, Dong H, Lu L, Hu HM, Wang LX. Tumor-released autophagosomes induce IL-10-producing B cells with suppressive activity on T lymphocytes via TLR2-MyD88-NF-κB signal pathway. Oncoimmunology 2016;5:e1180485. [PMID: 27622036 DOI: 10.1080/2162402X.2016.1180485] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 3.4] [Reference Citation Analysis]
37 Khlaiphuengsin A, Chuaypen N, Sodsai P, Buranapraditkun S, Boonpiyathad T, Hirankarn N, Tangkijvanich P. Decreased of BAFF-R expression and B cells maturation in patients with hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol 2020;26:2645-56. [PMID: 32523317 DOI: 10.3748/wjg.v26.i20.2645] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Shang J, Zha H, Sun Y. Phenotypes, Functions, and Clinical Relevance of Regulatory B Cells in Cancer. Front Immunol 2020;11:582657. [PMID: 33193391 DOI: 10.3389/fimmu.2020.582657] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
39 Allegra A, Musolino C, Tonacci A, Pioggia G, Casciaro M, Gangemi S. Clinico-Biological Implications of Modified Levels of Cytokines in Chronic Lymphocytic Leukemia: A Possible Therapeutic Role. Cancers (Basel) 2020;12:E524. [PMID: 32102441 DOI: 10.3390/cancers12020524] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
40 Marques P, Barry S, Carlsen E, Collier D, Ronaldson A, Awad S, Dorward N, Grieve J, Mendoza N, Muquit S, Grossman AB, Balkwill F, Korbonits M. Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours. Acta Neuropathol Commun 2019;7:172. [PMID: 31703742 DOI: 10.1186/s40478-019-0830-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 12.0] [Reference Citation Analysis]
41 Ding X, Zhao T, Lee CC, Yan C, Du H. Lysosomal Acid Lipase Deficiency Controls T- and B-Regulatory Cell Homeostasis in the Lymph Nodes of Mice with Human Cancer Xenotransplants. Am J Pathol 2021;191:353-67. [PMID: 33159889 DOI: 10.1016/j.ajpath.2020.10.007] [Reference Citation Analysis]
42 Chesneau M, Michel L, Dugast E, Chenouard A, Baron D, Pallier A, Durand J, Braza F, Guerif P, Laplaud DA. Tolerant Kidney Transplant Patients Produce B Cells with Regulatory Properties. J Am Soc Nephrol. 2015;26:2588-2598. [PMID: 25644114 DOI: 10.1681/asn.2014040404] [Cited by in Crossref: 90] [Cited by in F6Publishing: 40] [Article Influence: 15.0] [Reference Citation Analysis]
43 Xiao S, Brooks CR, Sobel RA, Kuchroo VK. Tim-1 is essential for induction and maintenance of IL-10 in regulatory B cells and their regulation of tissue inflammation. J Immunol 2015;194:1602-8. [PMID: 25582854 DOI: 10.4049/jimmunol.1402632] [Cited by in Crossref: 82] [Cited by in F6Publishing: 74] [Article Influence: 13.7] [Reference Citation Analysis]
44 Zhu J, Wang L, Zhou Y, Hao J, Wang S, Liu L, Li J. Comprehensive analysis of the relationship between competitive endogenous RNA (ceRNA) networks and tumor infiltrating-cells in hepatocellular carcinoma. J Gastrointest Oncol 2020;11:1381-98. [PMID: 33457008 DOI: 10.21037/jgo-20-555] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Wang Y, Schafer CC, Hough KP, Tousif S, Duncan SR, Kearney JF, Ponnazhagan S, Hsu HC, Deshane JS. Myeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5. J Immunol. 2018;201:278-295. [PMID: 29752311 DOI: 10.4049/jimmunol.1701069] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 11.7] [Reference Citation Analysis]
46 Isaeva OI, Sharonov GV, Serebrovskaya EO, Turchaninova MA, Zaretsky AR, Shugay M, Chudakov DM. Intratumoral immunoglobulin isotypes predict survival in lung adenocarcinoma subtypes. J Immunother Cancer 2019;7:279. [PMID: 31665076 DOI: 10.1186/s40425-019-0747-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
47 Weir GM, Hrytsenko O, Stanford MM, Berinstein NL, Karkada M, Liwski RS, Mansour M. Metronomic cyclophosphamide enhances HPV16E7 peptide vaccine induced antigen-specific and cytotoxic T-cell mediated antitumor immune response. Oncoimmunology 2014;3:e953407. [PMID: 25960932 DOI: 10.4161/21624011.2014.953407] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
48 Wang K, Gong H, Chai R, Yuan H, Chen Y, Liu J. RETRACTED: Aberrant frequency of IL-35 producing B cells in colorectal cancer patients. Cytokine 2018;102:206-10. [PMID: 29054723 DOI: 10.1016/j.cyto.2017.10.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
49 Mao H, Pan F, Guo H, Bu F, Xin T, Chen S, Guo Y. Feedback mechanisms between M2 macrophages and Th17 cells in colorectal cancer patients. Tumor Biol 2016;37:12223-30. [DOI: 10.1007/s13277-016-5085-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
50 Chen K, Wang Q, Li M, Guo H, Liu W, Wang F, Tian X, Yang Y. Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression. EBioMedicine 2021;66:103315. [PMID: 33819739 DOI: 10.1016/j.ebiom.2021.103315] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Sang W, Zhang Z, Dai Y, Chen X. Recent advances in nanomaterial-based synergistic combination cancer immunotherapy. Chem Soc Rev 2019;48:3771-810. [DOI: 10.1039/c8cs00896e] [Cited by in Crossref: 126] [Cited by in F6Publishing: 24] [Article Influence: 63.0] [Reference Citation Analysis]
52 Ding Q, Mohib K, Kuchroo VK, Rothstein DM. TIM-4 Identifies IFN-γ-Expressing Proinflammatory B Effector 1 Cells That Promote Tumor and Allograft Rejection. J Immunol 2017;199:2585-95. [PMID: 28848066 DOI: 10.4049/jimmunol.1602107] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
53 Gao W, Zhou J, Ji B. Evidence of Interleukin 21 Reduction in Osteosarcoma Patients Due to PD-1/PD-L1-Mediated Suppression of Follicular Helper T Cell Functionality. DNA Cell Biol 2017;36:794-800. [PMID: 28650673 DOI: 10.1089/dna.2017.3669] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
54 Wang X, Zhao X, Feng C, Weinstein A, Xia R, Wen W, Lv Q, Zuo S, Tang P, Yang X, Chen X, Wang H, Zang S, Stollings L, Denning TL, Jiang J, Fan J, Zhang G, Zhang X, Zhu Y, Storkus W, Lu B. IL-36γ Transforms the Tumor Microenvironment and Promotes Type 1 Lymphocyte-Mediated Antitumor Immune Responses. Cancer Cell 2015;28:296-306. [PMID: 26321222 DOI: 10.1016/j.ccell.2015.07.014] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 8.7] [Reference Citation Analysis]
55 Reed CM, Cresce ND, Mauldin IS, Slingluff CL Jr, Olson WC. Vaccination with Melanoma Helper Peptides Induces Antibody Responses Associated with Improved Overall Survival. Clin Cancer Res 2015;21:3879-87. [PMID: 25967144 DOI: 10.1158/1078-0432.CCR-15-0233] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
56 Li R, Dubinett SM. Myeloid-derived suppressor cell-dependent inhibition of B cell responses in non-small cell lung cancer. Transl Lung Cancer Res 2019;8:S331-3. [PMID: 32038908 DOI: 10.21037/tlcr.2019.04.10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Ganti SN, Albershardt TC, Iritani BM, Ruddell A. Regulatory B cells preferentially accumulate in tumor-draining lymph nodes and promote tumor growth. Sci Rep 2015;5:12255. [PMID: 26193241 DOI: 10.1038/srep12255] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 6.2] [Reference Citation Analysis]
58 Stikvoort A, Chen Y, Rådestad E, Törlén J, Lakshmikanth T, Björklund A, Mikes J, Achour A, Gertow J, Sundberg B, Remberger M, Sundin M, Mattsson J, Brodin P, Uhlin M. Combining Flow and Mass Cytometry in the Search for Biomarkers in Chronic Graft-versus-Host Disease. Front Immunol 2017;8:717. [PMID: 28674539 DOI: 10.3389/fimmu.2017.00717] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
59 Gallego-Valle J, Pérez-Fernández VA, Correa-Rocha R, Pion M. Generation of Human Breg-Like Phenotype with Regulatory Function In Vitro with Bacteria-Derived Oligodeoxynucleotides. Int J Mol Sci 2018;19:E1737. [PMID: 29895745 DOI: 10.3390/ijms19061737] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
60 Buenrostro D, Mulcrone PL, Owens P, Sterling JA. The Bone Microenvironment: a Fertile Soil for Tumor Growth. Curr Osteoporos Rep 2016;14:151-8. [PMID: 27255469 DOI: 10.1007/s11914-016-0315-2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
61 Migliorini F, Maffulli N, Trivellas A, Eschweiler J, Tingart M, Driessen A. Bone metastases: a comprehensive review of the literature. Mol Biol Rep 2020;47:6337-45. [PMID: 32749632 DOI: 10.1007/s11033-020-05684-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
62 van Daalen EE, Rizzo R, Kronbichler A, Wolterbeek R, Bruijn JA, Jayne DR, Bajema IM, Rahmattulla C. Effect of rituximab on malignancy risk in patients with ANCA-associated vasculitis. Ann Rheum Dis. 2017;76:1064-1069. [PMID: 27899372 DOI: 10.1136/annrheumdis-2016-209925] [Cited by in Crossref: 53] [Cited by in F6Publishing: 41] [Article Influence: 10.6] [Reference Citation Analysis]
63 Liu J, Li Y, Lu Z, Gu J, Liang Y, Huang E, Wang Z, Zhang H, Wang L, Zhang D, Yu H, Liu R, Chu Y. Deceleration of glycometabolism impedes IgG-producing B-cell-mediated tumor elimination by targeting SATB1. Immunology 2019;156:56-68. [PMID: 30171602 DOI: 10.1111/imm.12998] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
64 Uher O, Caisova V, Hansen P, Kopecky J, Chmelar J, Zhuang Z, Zenka J, Pacak K. Coley's immunotherapy revived: Innate immunity as a link in priming cancer cells for an attack by adaptive immunity. Semin Oncol 2019;46:385-92. [PMID: 31739997 DOI: 10.1053/j.seminoncol.2019.10.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
65 Marques P, Grossman AB, Korbonits M. The tumour microenvironment of pituitary neuroendocrine tumours. Front Neuroendocrinol 2020;58:100852. [PMID: 32553750 DOI: 10.1016/j.yfrne.2020.100852] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
66 Germain C, Gnjatic S, Dieu-Nosjean MC. Tertiary Lymphoid Structure-Associated B Cells are Key Players in Anti-Tumor Immunity. Front Immunol 2015;6:67. [PMID: 25755654 DOI: 10.3389/fimmu.2015.00067] [Cited by in Crossref: 80] [Cited by in F6Publishing: 79] [Article Influence: 13.3] [Reference Citation Analysis]
67 Thomas A, Smitha T. Can B- cell based immunotherapy be our new perspective to exit cancer? J Oral Maxillofac Pathol 2020;24:15-7. [PMID: 32508441 DOI: 10.4103/jomfp.JOMFP_121_20] [Reference Citation Analysis]
68 Johnson LA, June CH. Driving gene-engineered T cell immunotherapy of cancer. Cell Res 2017;27:38-58. [PMID: 28025979 DOI: 10.1038/cr.2016.154] [Cited by in Crossref: 142] [Cited by in F6Publishing: 120] [Article Influence: 28.4] [Reference Citation Analysis]
69 Marshall EA, Ng KW, Kung SH, Conway EM, Martinez VD, Halvorsen EC, Rowbotham DA, Vucic EA, Plumb AW, Becker-Santos DD, Enfield KS, Kennett JY, Bennewith KL, Lockwood WW, Lam S, English JC, Abraham N, Lam WL. Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis. Mol Cancer 2016;15:67. [PMID: 27784305 DOI: 10.1186/s12943-016-0551-1] [Cited by in Crossref: 69] [Cited by in F6Publishing: 70] [Article Influence: 13.8] [Reference Citation Analysis]
70 Siewe B, Pham JT, Cohen M, Hessol NA, Levine A, Martinez-Maza O, Landay A. Dysregulated B-cell TLR2 expression and elevated regulatory B-cell frequency precede the diagnosis of AIDS-related non-Hodgkin lymphoma. AIDS 2015;29:1659-64. [PMID: 26372276 DOI: 10.1097/QAD.0000000000000687] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
71 Blomberg OS, Spagnuolo L, de Visser KE. Immune regulation of metastasis: mechanistic insights and therapeutic opportunities. Dis Model Mech 2018;11:dmm036236. [PMID: 30355585 DOI: 10.1242/dmm.036236] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 16.0] [Reference Citation Analysis]
72 Saulep-Easton D, Vincent FB, Quah PS, Wei A, Ting SB, Croce CM, Tam C, Mackay F. The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells. Leukemia 2016;30:163-72. [PMID: 26139429 DOI: 10.1038/leu.2015.174] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 8.3] [Reference Citation Analysis]
73 Wang K, Liu J, Li J. IL-35-producing B cells in gastric cancer patients. Medicine (Baltimore) 2018;97:e0710. [PMID: 29742730 DOI: 10.1097/MD.0000000000010710] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
74 Guy TV, Terry AM, Bolton HA, Hancock DG, Zhu E, Brink R, McGuire HM, Shklovskaya E, Fazekas de St. Groth B. Collaboration between tumor-specific CD4+ T cells and B cells in anti-cancer immunity. Oncotarget 2016;7:30211-29. [PMID: 27121060 DOI: 10.18632/oncotarget.8797] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
75 Gheybi MK, Farrokhi S, Ravanbod MR, Ostovar A, Mehrzad V, Nematollahi P. The correlation of CD19 + CD24 + CD38 + B cells and other clinicopathological variables with the proportion of circulating Tregs in breast cancer patients. Breast Cancer 2017;24:756-64. [DOI: 10.1007/s12282-017-0775-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
76 Maddur MS, Bayry J. B cells drive Th2 responses by instructing human dendritic cell maturation. Oncoimmunology 2015;4:e1005508. [PMID: 26155405 DOI: 10.1080/2162402X.2015.1005508] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
77 Fontoura IC, Trombone AP, Almeida LP, Lorenzi JC, Rossetti RA, Malardo T, Padilha E, Schluchting W, Silva RL, Gembre AF, Fiuza JE, Silva CL, Panunto-Castelo A, Coelho-Castelo AA. B cells expressing IL-10 mRNA modulate memory T cells after DNA-Hsp65 immunization. Braz J Med Biol Res 2015;48:1095-100. [PMID: 26397973 DOI: 10.1590/1414-431X20154409] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]